Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Anna Schreiber

Concepts (45)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Anna Schreiber's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Anna Schreiber has written about over time.
Camptothecin, 3 publications between 2016 and 2023, average publication date August 2020. Antibodies, Monoclonal, Humanized, 1 publications between 2021 and 2021, average publication date October 2021. Kaplan-Meier Estimate, 1 publications between 2021 and 2021, average publication date October 2021. Neoplasm Staging, 1 publications between 2021 and 2021, average publication date October 2021. Immunoconjugates, 2 publications between 2021 and 2023, average publication date October 2022. Anthracyclines, 3 publications between 2021 and 2023, average publication date December 2022. Chemotherapy, Adjuvant, 3 publications between 2021 and 2023, average publication date December 2022. Medicare, 3 publications between 2021 and 2023, average publication date December 2022. Taxoids, 3 publications between 2021 and 2023, average publication date December 2022. Triple Negative Breast Neoplasms, 6 publications between 2021 and 2024, average publication date February 2023. Breast Neoplasms, 4 publications between 2021 and 2023, average publication date February 2023. Fetomaternal Transfusion, 1 publications between 2023 and 2023, average publication date August 2023. Fetus, 1 publications between 2023 and 2023, average publication date August 2023. Graft vs Host Disease, 1 publications between 2023 and 2023, average publication date August 2023. Hematopoietic Stem Cell Transplantation, 1 publications between 2023 and 2023, average publication date August 2023. Pregnancy Complications, 1 publications between 2023 and 2023, average publication date August 2023. Receptor, ErbB-2, 1 publications between 2023 and 2023, average publication date October 2023. Trastuzumab, 1 publications between 2023 and 2023, average publication date October 2023. Myocardial Infarction, 1 publications between 2023 and 2023, average publication date November 2023. Histone Deacetylase Inhibitors, 1 publications between 2024 and 2024, average publication date February 2024.

To see the data from this visualization as text, click here.
Schreiber's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)